Abstract:Serotonergic (5-HT) drugs are widely used in the clinical management of mood and anxiety disorders. However, it is reported that acute 5-HT treatment elicits anxiogenic-like behavior. Interestingly, the periaqueductal gray (PAG), a midbrain structure which regulates anxiety behavior - has robust 5-HT fibers and reciprocal connections with the hypothalamic-pituitary-adrenal (HPA) axis. Although the HPA axis and the 5-HT system are well investigated, the relationship between the stress hormones induced by 5-HT drug treatment and the PAG neural correlates of the behavior remain largely unknown. In this study, the effects of acute and chronic treatments with buspirone (BUSP) and escitalopram (ESCIT) on anxiety-related behaviors were tested in an open-field (OF). The treatment effects on PAG c-Fos immunoreactivity (c-Fos-ir) and corticosterone (CORT) concentration were measured in order to determine the neural-endocrine correlates of anxiety-related behaviors and drug treatments. Our results demonstrate that acute BUSP and ESCIT treatments induced anxiogenic behaviors with elevation of CORT compared to the baseline. A decrease of c-Fos-ir was found in the dorsomedial PAG region of both the treatment groups. Correlation analysis showed that the CORT were not associated with the OF anxiogenic behavior and PAG c-Fos-ir. No significant differences were found in behaviors and CORT after chronic treatment. In conclusion, acute BUSP and ESCIT treatments elicited anxiogenic response with activation of the HPA axis and reduction of c-Fos-ir in the dorsomedial PAG. Although no correlation was found between the stress hormone and the PAG c-Fos-ir, this does not imply the lack of cause-and-effect relationship between neuroendocrine effects and PAG function in anxiety responses. These correlation studies suggest that the regulation of 5-HT system was probably disrupted by acute 5-HT treatment.

Acute Administration of Buspirone Increases the Escape of Hypothalamic-Pituitary-adrenal-axis Hormones from Suppression by Dexamethasone in Depression.

Stimulatory Effects of L-5-Hydroxytryptophan on Postdexamethasone Β-Endorphin Levels in Major Depression

Effects of Buspirone on Plasma Prolactin and Cortisol-Levels in Major Depressed and Normal Subjects

Effects of Serotonin Precursors on the Negative Feedback Effects of Glucocorticoids on Hypothalamic-Pituitary-adrenal Axis Function in Depression

Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients.

The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients

In Search of the HPA Axis Activity in Unipolar Depression Patients with Childhood Trauma: Combined Cortisol Awakening Response and Dexamethasone Suppression Test

An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression

L-5-Hydroxytryptophan Stimulated Cortisol Escape from Dexamethasone Suppression in Melancholic Patients

Adrenocorticotropic hormone, β-endorphin and cortisol responses to oCRH in Unipolar Depressed Patients Pretreated with Dexamethasone

A further investigation of basal HPT axis function in unipolar depression: effects of diagnosis, hospitalization, and dexamethasone administration.

A Multivariate Study of Simultaneous Escape from Suppression by Dexamethasone of Urinary Free Cortisol, Plasma Cortisol, Adrenocorticotropic Hormone and Beta-Endorphin in Melancholic Patients.

An augmented escape of β-endorphins to suppression by dexamethasone in severely depressed patients

Pituitary and adrenal hormone responsiveness to Synachten in melancholic subjects versus subjects with minor depression

The Relationships Between The Cortisol Responses To Dexamethasone And To L-5-Htp, And The Availability Of L-Tryptophan In Depressed Females

Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients.

The Cortisol Responses to 5-Hydroxytryptophan, Orally, in Depressive Inpatients.

HPA-axis Hormones and Prolactin Responses to Dextro-Fenfluramine in Depressed Patients and Healthy Controls.

Acute serotonergic treatment changes the relation between anxiety and HPA-axis functioning and periaqueductal gray activation

Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.

Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.